The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
De novo mutations in schizophrenia implicate synaptic networks
Open accessAbstract
Inherited alleles account for most of the genetic risk for schizophrenia. However, new (de novo) mutations, in the form of large chromosomal copy number changes, occur in a small fraction of cases and disproportionally disrupt genes encoding postsynaptic proteins. Here we show that small de novo mutations, affecting one or a few nucleotides, are overrepresented among glutamatergic postsynaptic proteins comprising activity-regulated cytoskeleton-associated protein (ARC) and N-methyl-d-aspartate receptor (NMDAR) complexes. Mutations are additionally enriched in proteins that interact with these complexes to modulate synaptic strength, namely proteins regulating actin filament dynamics and those whose messenger RNAs are targets of fragile X mental retardation protein (FMRP). Genes affected by mutations in schizophrenia overlap those mutated in autism and intellectual disability, as do mutation-enriched synaptic pathways. Aligning our findings with a parallel case-control study, we demonstrate reproducible insights into aetiological mechanisms for schizophrenia and reveal pathophysiology shared with other neurodevelopmental disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“While most children with SCN2A variants fit into one of these three categories, there are some exceptions, including epileptic encephalopathy with choreoathetoid movements [26,27], benign infantile seizures with late-onset episodic ataxia [28–31], childhood-onset epileptic encephalopathy [32], and schizophrenia [33,34].”
From Progress in Understanding and Treating SCN2A-Mediated Disorders (2018) · cites this paper as [33]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The human NDR2 gene (STK38l) has been identified as a susceptibility gene for neurodevelopmental disorders, intellectual disability (Madencioglu et al. 2021; Firth et al. 2009), and autism spectrum disorder (Fromer et al. 2014).”
From The Serine/Threonine Kinase NDR2 Regulates Integrin Signaling, Synapse Formation, and Synaptic Plasticity in the Hippocampus (2025) · cites this paper as Fromer et al. 2014
Experimental — accuracy not yet measuredIn the citing paper
“We tested for and found that genes in which rare variants increase risk of ASD and DD32,33 are also enriched for schizophrenia common variant associations.”
From Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) · cites this paper as [32]
In the citing paper
“We controlled for a set of 10,360 genes with detectable expression in brain tissue measured as Fragments Per Kilobase of transcript per Million mapped reads (FPKM)32 to detect synaptic signals above signals simply reflecting the property of brain expression.”
From Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) · cites this paper as [32]
In the citing paper
“Thus, many severe mutations do not converge on one specific phenotype but instead seem to cause a range of clinical disorders74,76,80,81,84,87,91.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [80]
In the citing paper
“Protein-truncating variants (PTVs) are among the most interpretable associations as they suggest that the effect on disease most commonly tracks with decreasing expression of the gene18.”
From Rare coding variants in ten genes confer substantial risk for schizophrenia (2022) · cites this paper as [18]
In the citing paper
“This elevation of protein-compromising URVs was several times larger than an analogously elevated rate for de novo mutations”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“A strong and consistent finding in exome-sequencing studies of schizophrenia involves an excess of variants in genes whose mRNAs are bound by the fragile X mental retardation protein (FMRP)9,12,27.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“we identified an ultra-rare splice donor variant in TAF1312, an ultra-rare nonsense variant in SETD1A16,17, and a single ultra-rare nonsense variant in NRXN1, a gene in which exonic deletions associate with schizophrenia18.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“These data yielded an elevation of about 0.03 such DNMs per exome, based on the difference between rates of 0.185 (95% CI 0.151-0.219) for individuals with schizophrenia12 and 0.156 (95% CI 0.139-0.174) for unaffected individuals13.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“Estimated 3rd and 5th principal components corresponded to previously observed Finnish and Northern-Southern Sweden clines12 (Supplementary Fig. 12d)”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [12]
In the citing paper
“The available data are incomplete but implicate synaptic components, including calcium channel subunits and post-synaptic elements5–7.”
From Gene expression elucidates functional impact of polygenic risk for schizophrenia (2016) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., et al. (2012) · Nature · doi:10.1038/nature10989 · Cited by 2,165
Rate of de novo mutations and the importance of father’s age to disease risk
Kong, A., Frigge, M. L., Masson, G., Besenbacher, S., Sulem, P., Magnusson, G., Gudjonsson, S. A., Sigurdsson, A., Jonasdottir, A., Jonasdottir, A., et al. (2012) · Nature · doi:10.1038/nature11396 · Cited by 2,134
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072
Patterns and rates of exonic de novo mutations in autism spectrum disorders
Neale, B. M., Kou, Y., Liu, L., Ma’ayan, A., Samocha, K. E., Sabo, A., Lin, C.-F., Stevens, C., Wang, L.-S., Makarov, V., et al. (2012) · Nature · doi:10.1038/nature11011 · Cited by 1,734
Self-citationDiagnostic exome sequencing in persons with severe intellectual disability
de Ligt, J., Willemsen, M. H., van Bon, B. W. M., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206524 · Cited by 1,546
De Novo Gene Disruptions in Children on the Autistic Spectrum
Iossifov, I., Ronemus, M., Levy, D., Wang, Z., Hakker, I., Rosenbaum, J., Yamrom, B., Lee, Y.-H., Narzisi, G., Leotta, A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.04.009 · Cited by 1,446
Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence?
Feinberg, I. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90038-3 · Cited by 1,395
A polygenic burden of rare disruptive mutations in schizophrenia
Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P., O’Dushlaine, C., Chambert, K., Bergen, S. E., Kähler, A., et al. (2014) · Nature · doi:10.1038/nature12975 · Cited by 1,385
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–1,000 of 1,004
Nie, F., Zhang, Q., Ma, J., Wang, P., Gu, R., Han, J., & Zhang, R. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15225 · Cited by 16
Exploring the biological role of postzygotic and germinal de novo mutations in ASD
Alonso-González, A., Calaza, M., Amigo, J., González‐Peñas, J., Martínez-Regueiro, R., Fernández‐Prieto, M., Parellada, M., Arango, C., Rodriguez‐Fontenla, C., & Carracedo, Á. (2021) · Scientific Reports · doi:10.1038/s41598-020-79412-w · Cited by 16
Functional patient-derived cellular models for neuropsychiatric drug discovery
Lago, S. G., Tomasik, J., & Bahn, S. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01243-8 · Cited by 16
Gory‐Fauré, S., Powell, R., Jonckheere, J., Lanté, F., Denarier, É., Peris, L., Nguyen, C. H., Buisson, A., Lafanéchère, L., & Andrieux, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.627995 · Cited by 16
Zick, J. L., Crowe, D. A., Blackman, R. K., Schultz, K., Bergstrand, D. W., DeNicola, A. L., Carter, R. E., Ebner, T. J., Lanier, L. M., Netoff, T. I., et al. (2021) · Current Biology · doi:10.1016/j.cub.2021.10.009 · Cited by 16
Liu, Y., Qu, H., Chang, X., Tian, L., Glessner, J., Abou‐Sleiman, P. M., & Hakonarson, H. H. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.797329 · Cited by 16
Brennand, K. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20220235 · Cited by 16
Clifton, N. E., Bosworth, M. L., Haan, N., Rees, E., Holmans, P., Wilkinson, L. S., Isles, A. R., Collins, M. O., & Hall, J. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac105 · Cited by 16
Self-citationSebastian, R., Song, Y., & Pak, C. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.06.028 · Cited by 16
Ultrarare Coding Variants and Cognitive Function in Schizophrenia
Creeth, H., Rees, E., Legge, S. E., Dennison, C. A., Holmans, P., Walters, J., O’Donovan, M. C., & Owen, M. J. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.2289 · Cited by 16
Self-citationMartin, A. K., Robinson, G. A., Reutens, D. C., & Mowry, B. J. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.002 · Cited by 16
Where now for schizophrenia research?
Nutt, D., & Need, A. C. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.05.012 · Cited by 16
Assessment of Whole-Exome Sequence Data in Attempted Suicide within a Bipolar Disorder Cohort
Monson, E. T., Pirooznia, M., Parla, J. S., Kramer, M., Goes, F. S., Gaine, M. E., Gaynor, S. C., de Klerk, K., Jancic, D., Karchin, R., et al. (2017) · Complex Psychiatry · doi:10.1159/000454773 · Cited by 16
Suche nach Risikogenen bei Schizophrenie
Rujescu, D. (2017) · Der Nervenarzt · doi:10.1007/s00115-017-0330-2 · Cited by 16
PsyMuKB: An Integrative De Novo Variant Knowledge Base for Developmental Disorders
Lin, G. N., Guo, S., Xian, T., Wang, W., Qian, W., Song, W., Wang, J., Yu, S., Wang, Z., Cui, D., et al. (2019) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2019.10.002 · Cited by 16
Hyperactive ACC-MDT Pathway Suppresses Prepulse Inhibition in Mice
Kim, Y., Noh, Y. W., Kim, K., & Kim, E. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa090 · Cited by 16
Sluysmans, S., Méan, I., Jond, L., & Citi, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.729444 · Cited by 16
Antipsychotics and the Dopamine–Serotonin Connection
Ellenbroek, B. A., & Cesura, A. M. (2014) · Topics in medicinal chemistry · doi:10.1007/7355_2014_51 · Cited by 16
A Review of the Epidemiology of Schizophrenia
Brown, A. S., & Lau, F. S. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00002-x · Cited by 16
Kim, N.-S., Ringeling, F. R., Zhou, Y., Nguyen, H. N., Temme, S. J., Lin, Y.-T., Eacker, S., Dawson, V. L., Dawson, T. M., Xiao, B., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.04.023 · Cited by 15
John, J., Sharma, A. K., Kukshal, P., Triptish Bhatia, A., Nimgaonkar, V. L., Deshpande, S. N., & Thelma, B. K. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx196 · Cited by 15
Antipsychotic-induced epigenomic reorganization in frontal cortex of individuals with schizophrenia
Zhu, B., Ainsworth, R. I., Wang, Z., Liu, Z., Sierra, S., Deng, C., Callado, L. F., Meana, J. J., Wang, W., Lu, C., et al. (2023) · eLife · doi:10.7554/elife.92393 · Cited by 15
Piluso, G., Monteleone, P., Galderisi, S., Giugliano, T., Bertolino, A., Rocca, P., Rossi, A., Mucci, A., Aguglia, E., Andriola, I., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1395072 · Cited by 15
Assessment of Potential Clinical Role for Exome Sequencing in Schizophrenia
Balakrishna, T., & Curtis, D. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz057 · Cited by 15
Minkeviciene, R., Hlushchenko, I., Virenque, A., Lahti, L., Khanal, P., Rauramaa, T. H., Koistinen, A. P., Leinonen, V., Noè, F. M., & Hotulainen, P. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00276 · Cited by 15
Marzan, S., Aziz, M. A., & Islam, M. S. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01696-4 · Cited by 15
A novel stop-gain CUL3 mutation in a Japanese patient with autism spectrum disorder
Iwafuchi, S., Kikuchi, A., Endo, W., Inui, T., Aihara, Y., Satou, K., Kaname, T., & Kure, S. (2020) · Brain and Development · doi:10.1016/j.braindev.2020.09.015 · Cited by 15
Resolving cell state in iPSC-derived human neural samples with multiplexed fluorescence imaging
Tomov, M. L., O’Neil, A., Abbasi, H. S., Cimini, B. A., Carpenter, A. E., Rubin, L. L., & Bathe, M. (2021) · Communications Biology · doi:10.1038/s42003-021-02276-x · Cited by 15
Murch, O., Jain, V., Benneche, A., Metcalfe, K., Hobson, E., Prescott, K., Chandler, K., Ghali, N., Carmichael, J., Foulds, N. C., et al. (2021) · European Journal of Human Genetics · doi:10.1038/s41431-021-00961-3 · Cited by 15
EVL and MIM/MTSS1 regulate actin cytoskeletal remodeling to promote dendritic filopodia in neurons
Parker, S. S., Ly, K. T., Grant, A. D., Sweetland, J. A., Wang, A. M., Parker, J. D., Roman, M. R., Saboda, K., Roe, D. J., Padi, M., et al. (2023) · The Journal of Cell Biology · doi:10.1083/jcb.202106081 · Cited by 15
Fernandez, T. V., Williams, Z. P., Kline, T., Rajendran, S., Augustine, F., Wright, N. R. D., Sullivan, C. A. W., Olfson, E., Abdallah, S. B., Liu, W., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291978 · Cited by 15
Alterations in Prefrontal Cortical Circuitry and Cognitive Dysfunction in Schizophrenia
Lewis, D. A., & Glausier, J. R. (2016) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-3-319-30596-7_3 · Cited by 15
Laugel-Haushalter, V., Morkmued, S., Stoetzel, C., Geoffroy, V., Muller, J., Boland, A., Deleuze, J., Chennen, K., Pitiphat, W., Dollfus, H., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01329 · Cited by 15
The abiding relevance of mouse models of rare mutations to psychiatric neuroscience and therapeutics
Gogos, J. A., Crabtree, G. W., & Diamantopoulou, A. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.03.018 · Cited by 15
Tsavou, A., & Curtis, D. (2019) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000216 · Cited by 15
DeGiosio, R. A., Kelly, R. M., DeDionisio, A. M., Newman, J. T., Fish, K. N., Sampson, A. R., Lewis, D. A., & Sweet, R. A. (2019) · Schizophrenia · doi:10.1038/s41537-019-0081-0 · Cited by 15
John, J., Bhattacharyya, U., Yadav, N., Kukshal, P., Triptish Bhatia, A., Nimgaonkar, V. L., Deshpande, S. N., & Thelma, B. K. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.041 · Cited by 15
Novel Approaches for Identifying the Molecular Background of Schizophrenia
Golov, A. K., Kondratyev, N. V., Kostyuk, G. P., & Golimbet, A. V. E. (2020) · Cells · doi:10.3390/cells9010246 · Cited by 15
Potential synergistic action of 19 schizophrenia risk genes in the thalamus
Richard, E. A., Khlestova, E., Nanu, R., & Lisman, J. E. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.09.008 · Cited by 15
Adolescent neurostimulation of dopamine circuit reverses genetic deficits in frontal cortex function
Mastwal, S. S., Li, X., Stowell, R. D., Manion, M. T. C., Zhang, W., Kim, N., Yoon, K., Song, H., Ming, G., & Wang, K. H. (2023) · eLife · doi:10.7554/elife.87414 · Cited by 14
Gao, N., Liu, Z., Wang, H., Shen, C., Dong, Z., Cui, W., Xiong, W., & Mei, L. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0247-23.2023 · Cited by 14
González‐Peñas, J., Alloza, C., Brouwer, R. M., Díaz-Caneja, C. M., Costas, J., Lois, N. G., Gallego, A. G., de Hoyos, L., Gurriarán, X., Andreu-Bernabeu, Á., et al. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.03.011 · Cited by 14
Self-citationJohnson, K., Weldon, A. J., & Burmeister, M. A. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1386263 · Cited by 14
Broix, L., Roy, R., Shohayeb, B., Oomoto, I., Umeshima, H., & Wang, D. O. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115727 · Cited by 14
Duan, J. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-014-1488-2 · Cited by 14
Jambrina, E., Cerne, R., Smith, E. W., Scampavia, L. D., Cuadrado, M., Findlay, J. D., Krambis, M. J., Wakulchik, M., Chase, P. S., Brunavs, M., et al. (2016) · SLAS DISCOVERY · doi:10.1177/1087057116628437 · Cited by 14
Tang, W., Thevathasan, J. V., Lin, Q., Lim, K. B., Kuroda, K., Kaibuchi, K., Bilger, M., Soong, T. W., & Fivaz, M. L. (2016) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2016.00015 · Cited by 14
Introduction to Epigenetics in Psychiatry
Lee, R. S., & Avramopoulos, D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-417114-5.00001-2 · Cited by 14
Genetic Overlap Among Autism Spectrum Disorders and Other Neuropsychiatric Disorders
Morimoto, Y., Yamamoto, N., Kanegae, S., Matsuzaka, R., Ozawa, H., & Imamura, A. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.autismspectrumdisorders.2021.geneticoverlap · Cited by 14
Loss of POGZ alters neural differentiation of human embryonic stem cells
Deng, L., Mojica-Perez, S. P., Azaria, R. D., Schultz, M. L., Parent, J. M., & Niu, W. (2022) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2022.103727 · Cited by 14
The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System
Colizzi, M., Bortoletto, R., Costa, R., Bhattacharyya, S., & Balestrieri, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19095616 · Cited by 14
Jaehne, E. J., Ramshaw, H. S., Xu, X., Saleh, E., Clark, S. R., Schubert, K. O., Lopez, A. F., Schwarz, Q., & Baune, B. T. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.09.006 · Cited by 14
Gender differences in CNV burden do not confound schizophrenia CNV associations
Han, J., Walters, J., Kirov, G., Pocklington, A. J., Escott‐Price, V., Owen, M. J., Holmans, P., O’Donovan, M. C., & Rees, E. (2016) · Scientific Reports · doi:10.1038/srep25986 · Cited by 14
Self-citationGénétique et épigénétique de la schizophrénie et des psychoses
Chaumette, B., Kébir, O., & Krebs, M. (2017) · Biologie Aujourd hui · doi:10.1051/jbio/2017015 · Cited by 14
Schizophrenia: What’s Arc Got to Do with It?
Managò, F., & Papaleo, F. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00181 · Cited by 14
Castellani, C. A., Melka, M. G., Gui, J. L., Gallo, A. J., O’Reilly, R. L., & Singh, S. M. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0174-1 · Cited by 14
Gao, W., & Mack, N. R. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.618397 · Cited by 14
Wang, J., Li, X.-Y., Li, H., Liu, J.-W., Yao, Y., Li, M., Xiao, X., & Luo, X. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab032 · Cited by 14
Joe, P., Clemente, J. C., Piras, E., Wallach, D. S., Robinson‐Papp, J., Boka, E., Remsen, B., Bonner, M., Kimhy, D., Goetz, D. M., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.09.019 · Cited by 14
In vivo study sheds new light on the dendritic spine pathology hypothesis of schizophrenia
Li, W., Lv, L., & Luo, X. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01449-2 · Cited by 14
Control of CNS Functions by RNA-Binding Proteins in Neurological Diseases
Zhou, Y., Dong, F., & Mao, Y. (2018) · Current Pharmacology Reports · doi:10.1007/s40495-018-0140-7 · Cited by 14
Convergent and non-additive impact of schizophrenia risk genes in human neuronsPreprint
Deans, P. M., Townsley, K. G., Li, A., Seah, C., Johnson, J., García‐González, J., Cao, E., Schrode, N., Yu, A., Cartwright, S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.29.486286 · Cited by 14
Self-citationLiao, J., Dong, G., Wulaer, B., Sawahata, M., Mizoguchi, H., Mori, D., Ozaki, N., Nabeshima, T., Nagai, T., & Yamada, K. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113569 · Cited by 13
Kang, J., Jiao, Z., Qin, Y., Wang, Y., Wang, J., Li, J., Feng, J., Wang, F., Tang, Y., & Gong, X. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.12.043 · Cited by 13
Jia, L., Li, M., Pachernegg, S., Sedó, A., Jancovski, N., Burbano, L. E., Dalby, K., Nemiroff, A., Reid, C. A., Maljevic, S., et al. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16103 · Cited by 13
Çelebi, H. B. G., Bolat, H., & Ünsel‐Bolat, G. (2024) · Developmental Neurobiology · doi:10.1002/dneu.22941 · Cited by 13
Ben‐Mahmoud, A., Gupta, V. R., Aleem, A. K. A., Thompson, I. R., Aden, A., Mbarek, H., Saad, C., Tolefat, M., Alshaban, F. A. W., Stanton, L. W., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111551 · Cited by 14
Autoimmune neuropsychiatric disorders manifesting with psychosis
Cabrera‐Maqueda, J. M., Planagumà, J., Guasp, M., & Dalmau, J. O. (2025) · Journal of Clinical Investigation · doi:10.1172/jci196507 · Cited by 13
Durchbrüche im Verständnis der molekularen Ursachen psychiatrischer Störungen
Nöthen, M. M., Degenhardt, F., & Forstner, A. J. (2019) · Der Nervenarzt · doi:10.1007/s00115-018-0670-6 · Cited by 13
CRISPR-based functional evaluation of schizophrenia risk variants
Rajarajan, P., Flaherty, E. K., Akbarian, S., & Brennand, K. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.06.017 · Cited by 13
Characterization of Single Gene Copy Number Variants in Schizophrenia
Szatkiewicz, J., Fromer, M., Nonneman, R. J., Ancalade, N., Johnson, J., Stahl, E. A., Rees, E., Bergen, S. E., Hultman, C. M., Kirov, G., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.09.023 · Cited by 13
Self-citationJacob, M., Roach, B. J., Hamilton, H., Carrión, R. E., Belger, A., Duncan, E., Johannesen, J., Keshavan, M. S., Loo, S. K., Niznikiewicz, M. A., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.01.028 · Cited by 13
Cariboni, A. M., & Balasubramanian, R. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819973-2.00022-8 · Cited by 13
Hu, T., Wu, C., Hsu, S.-H., Tsai, H.-Y., Cheng, F.-Y., & Cheng, M.-C. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050783 · Cited by 13
Durankuş, F., Albayrak, Y., Erdoğan, F., Albayrak, N., Erdoğan, M. A., & Erbaş, O. (2022) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10221 · Cited by 13
Berryer, M. H., Rizki, G., Nathanson, A. J., Klein, J. A., Trendafilova, D., Susco, S. G., Lam, D., Messana, A., Holton, K. M., Karhohs, K. W., et al. (2023) · eLife · doi:10.7554/elife.80168 · Cited by 14
Thygesen, J. H., Zambach, S. K., Ingason, A., Lundin, P., Hansen, T. F., Bertalan, M., Rosengren, A., Bjerre, D., Ferrero‐Miliani, L., Rasmussen, H. B., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.08.037 · Cited by 13
The impact of genetics on future drug discovery in schizophrenia
Matsumoto, M., Walton, N. M., Yamada, H., Kondo, Y., Marek, G. J., & Tajinda, K. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1324419 · Cited by 13
Shifting the focus toward rare variants in schizophrenia to close the gap from genotype to phenotype
Bustamante, M. L., Herrera, L., Gaspar, P. A., Nieto, R. R., Maturana, A., Villar, M. J., Salinas, V., & Hernán Silva, I. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32550 · Cited by 13
Zhou, X., Batzoglou, S., Sidow, A., & Zhang, L. (2018) · BMC Genomics · doi:10.1186/s12864-018-4867-7 · Cited by 13
Aguirre-Chen, C., Stec, N., Ramos, O. M., Kim, N., Kramer, M., McCarthy, S., Gillis, J., McCombie, W. R., & Hammell, C. M. (2020) · G3 Genes Genomes Genetics · doi:10.1534/g3.119.400925 · Cited by 14
Systems Level Analysis and Identification of Pathways and Key Genes Associated with Delirium
Takahashi, Y., Terada, T., & Muto, Y. (2020) · Genes · doi:10.3390/genes11101225 · Cited by 13
Li, Y., Li, S., Liu, J., Huo, Y., & Luo, X. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01261-4 · Cited by 13
Characterization of the zinc-induced Shank3 interactome of mouse synaptosome
Lee, Y., Ryu, J. R., Kang, H., Kim, Y., Kim, S., Zhang, Y., Jin, C., Cho, H. M., Kim, W.-K., Sun, W., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.143 · Cited by 13
nArgBP2-SAPAP-SHANK, the core postsynaptic triad associated with psychiatric disorders
Lee, S., Kim, J. A., & Chang, S. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-017-0018-5 · Cited by 13
Kummerfeld, E., Ma, S., Blackman, R. K., DeNicola, A. L., Redish, A. D., Vinogradov, S., Crowe, D. A., & Chafee, M. V. (2020) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2020.02.013 · Cited by 13
Rare variants are common in schizophrenia
Gratten, J. (2016) · Nature Neuroscience · doi:10.1038/nn.4422 · Cited by 12
Weickert, T. W., Ji, E., Galletly, C. A., Boerrigter, D., Morishima, Y., Bruggemann, J. M., Balzan, R. P., O׳Donnell, M., Liu, D., Lenroot, R., et al. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad171 · Cited by 12
The genetics of cognition in schizophrenia
Owen, M. J., & O’Donovan, M. C. (2024) · Genomic psychiatry : · doi:10.61373/gp024i.0040 · Cited by 12
Self-citationBridging molecular and cellular neuroscience with proximity labeling technologies
Lee, J.-G., Jeong, I., & Kim, K.-E. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01491-4 · Cited by 12
Dixson, L., Walter, H., Schneider, M., Erk, S., Schäfer, A., Haddad, L., Grimm, O., Mattheisen, M., Nöthen, M. M., Cichon, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404082111 · Cited by 12
RetractedXu, N., Shi, W., Cao, X., Zhou, X., Li, J., Huang, H., Chen, S., & Xu, C. (2023) · Journal of Medical Genetics · doi:10.1136/jmg-2022-108920 · Cited by 12
Genomic insights into schizophrenia
Owen, M. J. (2023) · Royal Society Open Science · doi:10.1098/rsos.230125 · Cited by 12
Self-citationForsyth, J. K., & Bearden, C. E. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230736 · Cited by 12
Takagi, S., Balu, D. T., & Coyle, J. T. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.12.034 · Cited by 12
Association of oligodendrocytes differentiation regulator geneDUSP15with autism
Tian, Y., Wang, L., Jia, M., Lu, T., Ruan, Y., Wu, Z., Wang, L., Liu, J., & Zhang, D. (2016) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1178395 · Cited by 12
John, J., Kukshal, P., Sharma, A. K., Triptish Bhatia, A., Nimgaonkar, V. L., Deshpande, S. N., & Thelma, B. K. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.12.012 · Cited by 12
Yousaf, S., King, P. J. S., Miller, A. F., Saiani, A., Clarke, D. J., Trivoluzzi, L. T., Aojula, H. S., & Bichenkova, E. V. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b01841 · Cited by 12
Courtois, E., Schmid, M., Wajsbrot‐Elgrabli, O., Barau, C., Corvoisier, P. L., Aouizerate, B., Bellivier, F., Belzeaux-R, R., Dubertret, C., Kahn, J., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0783-0 · Cited by 12
Genetic and epigenetic analyses of panic disorder in the post-GWAS era
Morimoto, Y., Ono, S., Kurotaki, N., Imamura, A., & Ozawa, H. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02205-y · Cited by 12
Metadata
- Authors
- Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D. M., Carrera, N., Humphreys, I., Johnson, J. S., Roussos, P., Barker, D. D., Banks, E., Milanova, V., Grant, S. G., Hannon, E., Rose, S. A., Chambert, K., Mahajan, M., Scolnick, E. M., Moran, J. L., Kirov, G., Palotie, A., McCarroll, S. A., Holmans, P., Sklar, P., Owen, M. J., Purcell, S. M., & O’Donovan, M. C.
- Affiliations
- Broad Institute (US)
- Cardiff University (GB)
- University of Helsinki (FI)
- Icahn School of Medicine at Mount Sinai (US)
- Medical University of Sofia (BG)
- University of Edinburgh (GB)
- Corresponding author
- Owen, Michael J.
- ORCID
- Fromer, Menachem
- Pocklington, Andrew J.
- Williams, Hywel J.
- Dwyer, Sarah
- Gormley, Padhraig
- Rees, Elliott
- Palta, Priit
- Ruderfer, Douglas M.
- Carrera, Noa
- Johnson, Jessica S.
- Roussos, Panos
- Banks, Eric
- Milanova, Vihra
- Grant, Seth G.
- Hannon, Eilis
- Rose, Samuel A.
- Scolnick, Edward M.
- Moran, Jennifer L.
- Kirov, George
- Palotie, Aarno
- McCarroll, Steven A.
- Holmans, Peter
- Sklar, Pamela
- Owen, Michael J.
- Purcell, Shaun M.
- O’Donovan, Michael C.
- Venue
- Nature
- Published
- 2014-01-22
- Volume
- 506
- Issue
- 7487
- Pages
- 179-184
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4237002
- OpenAlex
- W2023962370
- Cited by
- 1,617
- References
- 43
- Citations by year
- 2026: 39 · 2025: 68 · 2024: 64 · 2023: 91 · 2022: 114 · 2021: 134 · 2020: 127 · 2019: 168 · 2018: 149 · 2017: 193 · 2016: 186 · 2015: 164 · 2014: 120
- FWCI
- 168.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01BX002395)
- Wellcome Trust (089062, WT 098051, WT089062, 098051)
- Medical Research Council (MR/L010305/1)
- National Institute of Mental Health (P50MH066392, R01MH071681, R01MH099126)
- National Human Genome Research Institute (R01HG005827)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- schizophrenia, de novo mutations, synaptic proteins, glutamatergic synapses, activity-regulated cytoskeleton-associated protein, NMDA receptor, FMRP, actin filament dynamics, autism spectrum disorder, intellectual disability, neurodevelopmental disorders, synaptic efficacy
- MeSH terms
- Child Development Disorders, Pervasive, Cytoskeletal Proteins, Humans, Intellectual Disability, Models, Neurological, Mutation, Nerve Net, Nerve Tissue Proteins, Neural Pathways, Phenotype, RNA, Messenger, Schizophrenia, Substrate Specificity, Synapses, Receptors, N-Methyl-D-Aspartate, Fragile X Messenger Ribonucleoprotein 1, Exome, Mutation Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
